Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

01. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3034


	Artikel 1 - 20 / 60677

	Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer. Front Immunol Zhu H, Yi W, Wu Y, Li R, Zhou B. PMID: 42382771 [PubMed - in process]
	A Single Institution Experience with Pancreatic Carcinoma: A Retrospective Study. Indian J Surg Oncol Trivedi S, Varun M, Bharadwaj A, Patel S, Sharma M, Warikoo V, Puj K, Salunke A, Tripathi U, Pandya S. PMID: 42381806 [PubMed - in process]
	Cardiovascular-Kidney-Metabolic Syndrome, Healthy Lifestyles, and Risk of Cancer Incidence and Mortality: AÂ Prospective Cohort Study. Int J Cancer Qie R, Liu H, Liu Y, Guo X, Chen Q, Xu H, Wang X, Kang R, Cheng C, Zhao M, Wang H, Zheng L, Liu S, Zhang S. PMID: 42381231 [PubMed - as supplied by publisher]
	Defining the Incremental Value of Endoscopic Ultrasound in Assessing Pancreatic Cystic Neoplasms. Ann Surg Tocci NX, Deverakonda DL, Schmidt EM, Ansari P, Wehrle CJ, Allkushi E, Bennett WC, Tu C, Perlmutter B, McMichael J, Augustin T, Naffouje S, Joyce D, Naples R, Simon R, Walsh RM. PMID: 42381052 [PubMed - as supplied by publisher]
	Clinical Implementation Gap of Comprehensive Genomic Profiling in Pancreatic Cancer: A Real-world Study. In Vivo Ando M, Inoue T, Iwata T, Kubo A, Fukami Y, Sano T. PMID: 42379797 [PubMed - in process]
	Textbook Outcome/Textbook Oncological Outcome for Pancreatic Cancer Treatment. In Vivo Aoyama T, Cho H, Saito A. PMID: 42379736 [PubMed - in process]
	Large Language Model Versus Multidisciplinary Team: Feasibility Study of Pancreatic Cancer Management Recommendations. J Med Internet Res Liu Z, Zhao X, Mao T, Zhou H, Jiang K. PMID: 42379138 [PubMed - in process]
	Comparing oncologic and surgical outcomes of robotic and open pancreatoduodenectomy: an updated meta-analysis. Surg Endosc Parker CH, Ferretti AM, Yaramada L, Restle DJ, Parsa S, Liao Y, Georgakis GV. PMID: 42377469 [PubMed - indexed for MEDLINE]
	DNA damage response inhibitors in pancreatic cancer: progress and challenges. Front Oncol Wu Y, Li W, Wu M. PMID: 42376674 [PubMed]
	Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic neoplasms: a comprehensive review. Front Med (Lausanne) Sun X, Ge N. PMID: 42375187 [PubMed]
	Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types. Mol Med Gorbokon N, Teljuk K, Schraps N, Lennartz M, Rico SD, Kind S, Reiswich V, Viehweger F, Lutz F, Fraune C, Luebke AM, Menz A, Schlichter R, Krech T, Hinsch A, Burandt E, Sauter G, Simon R, Steurer S, Marx AH, Lebok P, Dum D, Minner S, Jacobsen F, Clauditz TS, Hackert T, Uzunoglu FG, Bernreuther C, Kluth M. PMID: 42374173 [PubMed - indexed for MEDLINE]
	Role of INSM1 expression in the diagnostic work-up of pancreatic acinar cell carcinoma with special reference to the differential diagnosis with neuroendocrine tumor. Virchows Arch Branca F, Marchiori D, Novarina S, Zaccaria M, Vanoli A, La Rosa S, Uccella S. PMID: 42373833 [PubMed - as supplied by publisher]
	Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Mechanisms and Therapeutic Strategies. Anticancer Res Ahn D, Choi KC. PMID: 42373267 [PubMed - indexed for MEDLINE]
	Factors Associated With Refusal of Surgery for PDAC and Its Impact: An NCDB Analysis. Anticancer Res Manaise HK, Mahesh VA, Yadav A, Puri R, Aguayo-Merly A, Bowers J, Jimenez PB, Demirors B, Gabriel EM. PMID: 42373259 [PubMed - indexed for MEDLINE]
	Association Between Geriatric Nutritional Risk Index and Gemcitabine Plus Nab-Paclitaxel Continuation in Elderly Patients With Pancreatic Cancer. Anticancer Res Takigawa M, Miura C, Sato A, Hirai S, Kimura Y, Kinoshita M, Doi H, Masuda M. PMID: 42373239 [PubMed - indexed for MEDLINE]
	Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. JCO Precis Oncol Moravec S, Barton LV, Suresh R, Hayward L, Schmidlen T, Rivera JNR, Basinski T, Alhassan S, Nardella N, Oraiqat A, Craig L, Cooper L, Blanquicett CJ, Maharaj SS, Blue K, Adams M, Kim R, Biachi De Castria T, Malafa M, Sinnamon AJ, Pereira AL, Kim DW, Hoffe S, Hodul PJ, Vadaparampil ST, Ho TT, Hicks JK, Snir M, Permuth JB. PMID: 42372208 [PubMed - indexed for MEDLINE]
	Real-world safety, prognostic, and design considerations inÂ ketogenic diet trials for pancreatic cancer. Cancer Bruckner HW, Knopf E. PMID: 42371807 [PubMed - in process]
	Safety and efficacy of the MNK/VEGFR inhibitor JDB153 combined with the anti-PD-1 antibody serplulimab in patients with advanced pancreatic cancer refractory to standard treatment: a single-arm, phase Ib/II study protocol. Front Pharmacol Zhu X, Wei H, Cao D, Xu H. PMID: 42371576 [PubMed]
	Preoperative Systemic Pan-Immune-Inflammation Value Predicts Posthepatectomy Liver Failure After Laparoscopic Resection for Hepatocellular Carcinoma: A Retrospective Cohort Study. J Inflamm Res Wu X, Xu S, Zhang T, Xing Y, Min X, Wu J, Mao Q. PMID: 42371494 [PubMed]
	Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies. Target Oncol Valikovics AK, Bacsó D, Samaien N, das Virgens IPA, Szentes B, Agócs G, Obeidat M, Széll T, Hadaschik B, Hegyi P, Nyirády P, Szarvas T. PMID: 42371314 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 60677

Seite 1 von 3034



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung